BriaCell Therapeutics (BCTX) Earnings Date & Reports
A.I. Advisor
published Earnings
BCTX is expected to report earnings to fall 55.84% to -34 cents per share on September 21
Q2'23
Est.
$-0.34
Q1'23
Missed
by $0.41
Q4'22
Beat
by $0.26
Q3'22
Missed
by $0.74
Q2'22
Missed
by $0.11
The last earnings report on March 16 showed earnings per share of -76 cents, missing the estimate of -35 cents. With 69.82K shares outstanding, the current market capitalization sits at 12.82M.